Supply Chain
BD Pledges $19 Billion in U.S. Spending in Exchange for Relief From Future Medical-Device Tariffs
The agreement would lift the share of consumables BD supplies domestically to about 80% and make all its U.S. needles here. Relief is contingent on milestones and on final Section 232 determinations.
PR
By Priya Raghavan
Oct 6, 2026 · 2 min read
BD said Tuesday it has entered a partnership with the U.S. government under which it will invest $19 billion in the United States over several years, including $3 billion specifically for manufacturing expansion, in exchange for relief from future Section 232 tariffs on covered products and inputs.
Discussion (0)
Sign in to join the discussion.
Loading comments…
PR
Priya Raghavan
Corporate Insider Inc.
Priya Raghavan writes for Corporate Insider Inc.